Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;1212 Suppl 1(Suppl 1):E1-14.
doi: 10.1111/j.1749-6632.2010.05839.x.

Probiotics: from bench to market

Marguerite Klein  1 , Mary Ellen Sanders, Tri Duong, Howard A Young
Affiliations

Probiotics: from bench to market

Marguerite Klein et al. Ann N Y Acad Sci. 2010 Nov.

Abstract

"Probiotics: From Bench to Market" was a one-day conference convened by the New York Academy of Sciences on June 11, 2010, with the goal of stimulating discussion of the physiological effects of probiotics on the gastrointestinal, nervous, and immune systems. The program included speakers from academia, industry, and government to give conference participants a full understanding of the state of the field of probiotics. The overall goal of the program was to increase communication and collaboration among these groups to advance probiotic research and probiotic contributions to public health. The conference was divided into three sessions and included both oral and visual presentations as well as panel discussions.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
An important challenge facing the probiotic industry today is to understand the extent to which different factors influence probiotic physiology. Probiotic physiology will, in turn, influence in vivo functionality and stability. The extent to which these factors influence probiotic physiology should be expected to be strain-specific unless demonstrated otherwise. Demonstration of bioequivalency among different delivery formats and production methods is an important step in developing evidence-substantiating efficacy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hill C 2010. Probiotics and pharmabiotics. Bioengineered Bugs 1: 79–84. - PMC - PubMed
    1. Shanahan F, Stanton C, Ross P & Hill C. 2009. Pharmabiotics: Bioactives from mining host-microbe-dietary interactions. Functional Food Reviews 1: 20–25.
    1. Kubota A et al. 2009. Lactobacillus strains stabilize intestinal microbiota in Japanese cedar pollinosis patients. Microbiol. Immunol 53: 198–205. - PubMed
    1. Engelbrektson A et al. 2009. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J. Med. Microbiol 58: 663–670. - PubMed
    1. Whorwell PJ et al. 2006. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol 101: 1581–1590. - PubMed

Publication types